Background: Since the use of tissue plasminogen activator for acute ischemic stroke (IS), stroke care pathways have been developed for patients with suspicion of acute stroke. The aim of this prospective observational study was to analyze the stroke mimic (SM) characteristics in patients who were part of our stroke care pathway. Methods: All consecutive patients admitted in the code stroke within a 1-year period were prospectively enrolled in this study. Patients with a sudden onset of neurological focal deficit in a time window less than 4H30 as indicated for intravenous thrombolysis, had been accepted in the pathway by a neurologist who was directly contactable by the prehospital emergency medical service 24 h per day. Patients arrived directly on the MRI site without passing by the emergency department. A clinical neurological evaluation and a brain MRI with tri-dimensional time-of-flight magnetic resonance angiography were performed. The FAST score was calculated a posteriori. The final discharge diagnosis was concluded either immediately after both neurological examination and cerebrovascular neuroimaging or after other relevant investigations. We classified the discharge diagnosis into neurovascular diseases (NVDs) and into SM. Results: There were 1,361 consecutive patients admitted for suspicion of acute stroke. Sixty-two percent (n = 840) had an NVD including IS (n = 529), transient ischemic attacks (n = 236), intracranial hemorrhages (n = 68), cerebral venous thrombosis (n = 3) and neurovascular medullar pathologies (n = 4). SM represented 38% of cases (n = 521) and the most frequent discharge diagnosis was defined as headaches (18.6%), psychological disorders (16.7%), peripheral vertigo (11.9%) and epilepsy (10.6%). The comparison between the characteristics of the NVD and those of the SM groups showed some significant differences: in the SM group, women were more represented, patients were younger and the NIHSS was lower than in the NVD group. All cardiovascular risk factors were more represented in the NVD group. Concerning the symptoms, motor deficit, speech disturbances, homonymous lateral hemianopia and head and gaze deviation were more represented in the NVD group, whereas vertigo, non-systematized visual trouble, headache, confusion, weakness, neuropsychological symptoms, seizure and chest pain were significantly more frequent in the SM group. The negative predictive value of the FAST score was 64% and the positive predictive value was 76%. Conclusions: A rate of SM up to 38% of the code stroke system confirms the difficulty to distinguish clinically a stroke from another diagnosis. In this study, using cerebral MRI in first intention was of special interest in patients with acute neurological symptoms to differentiate an NVD from an SM.

1.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators: Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
2.
Rapp K, Bratina P, Barch C, Braimah J, Daley S, Donnarumma R, Kongable G, Sailor S, Spilker J: Code stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA stroke study group. J Neurosci Nurs 1997;29:361-366.
3.
De Luca A, Toni D, Lauria L, Sacchetti ML, Giorgi Rossi P, Ferri M, Puca E, Prencipe M, Guasticchi G; IMPLementazione Percorso Clinico Assistenziale ICtus Acuto (IMPLICA) Study Group: An emergency clinical pathway for stroke patients - results of a cluster randomised trial (isrctn41456865). BMC Health Serv Res 2009;9:14.
4.
Monks T, Pitt M, Stein K, James M: Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke 2012;43:2706-2711.
5.
Baldereschi M, Piccardi B, Di Carlo A, Lucente G, Guidetti D, Consoli D, Provinciali L, Toni D, Sacchetti ML, Polizzi BM, Inzitari D; Promotion and Implementation of Stroke Care in Italy Project - Working Group: Relevance of prehospital stroke code activation for acute treatment measures in stroke care: a review. Cerebrovasc Dis 2012;34:182-190.
6.
Boulter DJ, Schaefer PW: Stroke and stroke mimics: a pattern-based approach. Semin Roentgenol 2014;49:22-38.
7.
Merino JG, Luby M, Benson RT, Davis LA, Hsia AW, Latour LL, Lynch JK, Warach S: Predictors of acute stroke mimics in 8187 patients referred to a stroke service. J Stroke Cerebrovasc Dis 2013;22:e397-e403.
8.
Fernandes PM, Whiteley WN, Hart SR, Al-Shahi Salman R: Strokes: mimics and chameleons. Pract Neurol 2013;13:21-28.
9.
Dupre CM, Libman R, Dupre SI, Katz JM, Rybinnik I, Kwiatkowski T: Stroke chameleons. J Stroke Cerebrovasc Dis 2014;23:374-378.
10.
Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T, Jolley D, Donnan GA, Tress BM, Davis SM: Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 1999;30:2059-2065.
11.
Kurz KD, Ringstad G, Odland A, Advani R, Farbu E, Kurz MW: Radiological imaging in acute ischaemic stroke. Eur J Neurol 2016;23(suppl 1):8-17.
12.
Legrand L, Tisserand M, Turc G, Naggara O, Edjlali M, Mellerio C, Mas JL, Méder JF, Baron JC, Oppenheim C: Do FLAIR vascular hyperintensities beyond the DWI lesion represent the ischemic penumbra? AJNR Am J Neuroradiol 2015;36:269-274.
13.
Legrand L, Tisserand M, Turc G, Edjlali M, Calvet D, Trystram D, Roca P, Naggara O, Mas JL, Méder JF, Baron JC, Oppenheim C: Fluid-attenuated inversion recovery vascular hyperintensities-diffusion-weighted imaging mismatch identifies acute stroke patients most likely to benefit from recanalization. Stroke 2016;47:424-427.
14.
Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA: Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-76.
15.
Berglund A, Svensson L, Wahlgren N, von Euler M; HASTA Collaborators: Face arm speech time test use in the prehospital setting, better in the ambulance than in the emergency medical communication center. Cerebrovasc Dis 2014;37:212-216.
16.
Dalloz MA, Bottin L, Muresan IP, Favrole P, Foulon S, Levy P, Drouet T, Marro B, Alamowitch S: Thrombolysis rate and impact of a stroke code: a French hospital experience and a systematic review. J Neurol Sci 2012;314:120-125.
17.
Debiais S, Bonnaud I, Giraudeau B, Perrotin D, Gigot JL, Saudeau D, De Toffol B, Autret A: [Creation of a regional stroke network in Tours hospital (France): consequences for stroke care and thrombolysis]. Rev Neurol (Paris) 2007;163:817-822.
18.
Cramer SC, Stradling D, Brown DM, Carrillo-Nunez IM, Ciabarra A, Cummings M, Dauben R, Lombardi DL, Patel N, Traynor EN, Waldman S, Miller K, Stratton SJ: Organization of a United States county system for comprehensive acute stroke care. Stroke 2012;43:1089-1093.
19.
Haute Autorité de Santé: Accident vasculaire cérébral: prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse). Recommandations pour la bonne pratique. Saint-Denis La Plaine, HAS, 2009.
20.
Liu X, Almast J, Ekholm S: Lesions masquerading as acute stroke. J Magn Reson Imaging 2013;37:15-34.
21.
Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM: Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke 2006;37:769-775.
22.
Hemmen TM, Meyer BC, McClean TL, Lyden PD: Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J Stroke Cerebrovasc Dis 2008;17:23-25.
23.
Vroomen PC, Buddingh MK, Luijckx GJ, De Keyser J: The incidence of stroke mimics among stroke department admissions in relation to age group. J Stroke Cerebrovasc Dis 2008;17:418-422.
24.
Burke JF, Gelb DJ, Quint DJ, Morgenstern LB, Kerber KA: The impact of MRI on stroke management and outcomes: a systematic review. J Eval Clin Pract 2013;19:987-993.
25.
Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S: Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293-298.
26.
Kidwell CS, Hsia AW: Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI. Curr Neurol Neurosci Rep 2006;6:9-16.
27.
Artto V, Putaala J, Strbian D, Meretoja A, Piironen K, Liebkind R, Silvennoinen H, Atula S, Häppölä O; Helsinki Stroke Thrombolysis Registry Group: Stroke mimics and intravenous thrombolysis. Ann Emerg Med 2012;59:27-32.
28.
Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, Restrepo L: A model to prevent fibrinolysis in patients with stroke mimics. J Stroke Cerebrovasc Dis 2012;21:839-843.
29.
Davis S, Donnan GA: Time is Penumbra: imaging, selection and outcome. The Johann Jacob Wepfer award 2014. Cerebrovasc Dis 2014;38:59-72.
30.
Köhrmann M, Jüttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W: MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006;5:661-667.
31.
Gerischer LM, Fiebach JB, Scheitz JF, Audebert HJ, Endres M, Nolte CH: Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study. Cerebrovasc Dis 2013;35:250-256.
32.
Yoo SH, Kwon SU, Lee DH, Kim SJ, Kim JS, Kang DW: Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke. J Neurol Sci 2010;294:119-123.
33.
Kang DW, Chalela JA, Dunn W, Warach S; NIH-Suburban Stroke Center Investigators: MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 2005;36:1939-1943.
34.
Van Schaik SM, Scott S, de Lau LM, Van den Berg-Vos RM, Kruyt ND: Short door-to-needle times in acute ischemic stroke and prospective identification of its delaying factors. Cerebrovasc Dis Extra 2015;5:75-83.
35.
Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M: Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 2012;79:306-313.
36.
Shah S, Luby M, Poole K, Morella T, Keller E, Benson RT, Lynch JK, Nadareishvili Z, Hsia AW: Screening with MRI for accurate and rapid stroke treatment: SMART. Neurology 2015;84:2438-2444.
37.
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology: Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
38.
Advani R, Naess H, Kurz MW: Evaluation of the implementation of a rapid response treatment protocol for patients with acute onset stroke: can we increase the number of patients treated and shorten the time needed? Cerebrovasc Dis Extra 2014;4:115-121.
39.
González RG: Clinical MRI of acute ischemic stroke. J Magn Reson Imaging 2012;36:259-271.
40.
El Husseini N, Goldstein LB: ‘Code stroke': hospitalized versus emergency department patients. J Stroke Cerebrovasc Dis 2013;22:345-348.
41.
Moulin T, Sablot D, Vidry E, Belahsen F, Berger E, Lemounaud P, Tatu L, Vuillier F, Cosson A, Revenco E, Capellier G, Rumbach L: Impact of emergency room neurologists on patient management and outcome. Eur Neurol 2003;50:207-214.
42.
Kleindorfer DO, Miller R, Moomaw CJ, Alwell K, Broderick JP, Khoury J, Woo D, Flaherty ML, Zakaria T, Kissela BM: Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke 2007;38:2864-2868.
43.
Goldstein LB, Simel DL: Is this patient having a stroke? JAMA 2005;293:2391-2402.
44.
Newman-Toker DE, Robinson KA, Edlow JA: Frontline misdiagnosis of cerebrovascular events in the era of modern neuroimaging: a systematic review. Ann Neurol 2008;64(suppl 12):S17-S18.
45.
Pope JV, Edlow JA: Avoiding misdiagnosis in patients with neurological emergencies. Emerg Med Int 2012;2012:949275.
46.
Kuruvilla A, Bhattacharya P, Rajamani K, Chaturvedi S: Factors associated with misdiagnosis of acute stroke in young adults. J Stroke Cerebrovasc Dis 2011;20:523-527.
47.
Edlow JA, Selim MH: Atypical presentations of acute cerebrovascular syndromes. Lancet Neurol 2011;10:550-560.
48.
Lahr MM, Luijckx GJ, Vroomen PC, van der Zee DJ, Buskens E: The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models. J Neurol 2013;260:960-968.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.